Open Access
Volume 18, Number 5, Septembre-Octobre 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Deuxième partie)
Page(s) 267 - 270
Section PUFA and Neuroprotection
Published online 15 September 2011
  • ADI. World Alzheimer report 2010: The global economic impact of dementia. In: Accessed 25 May 2011 at [Google Scholar]
  • Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007; 69: 1921–1930. [CrossRef] [PubMed] [Google Scholar]
  • Broersen LM, De Wilde MIL, Kuipers AAM, Van Wijk NW, Kamphuis PJ, Van der Beek EM. Reduced beta-amyloid plaque burden and neurodegeneration in APP/PS1 transgenic mice following multi-nutrient dietary intervention. Society for Neuroscience (San Diego, CA) Programme number 157.116/U127. 2007. [Google Scholar]
  • Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 2007; 148: 421–431. [CrossRef] [PubMed] [Google Scholar]
  • Cansev M, Ulus IH, Wang L, Maher TJ, Wurtman RJ. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson’s disease. Neurosci Res 2008; 62: 206–209. [CrossRef] [PubMed] [Google Scholar]
  • Cansev M, Marzloff G, Sakamoto T, Ulus IH, Wurtman RJ. Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups. Dev Neurosci 2009; 31: 181–192. [CrossRef] [PubMed] [Google Scholar]
  • Citron M. Alzheimer’s disease: treatments in discovery and development. Nat Neurosci 2002; (Suppl 5) 1055–1057. [CrossRef] [PubMed] [Google Scholar]
  • de Wilde MC, Kamphuis P, Sijben JWC, Scheltens P. Utility of imaging for nutritional intervention studies in Alzheimer’s disease. European Journal of Pharmacology. Article online. 2011a. [Google Scholar]
  • de Wilde MC, Penke B, van der Beek EM, Kuipers AAM, Kamphuis PJ, Broersen LM. Neuroprotective effects of a specific multi-nutrient intervention against Aß42-induced toxicity in rats. Journal of Alzheimers disease. 2011b. [Google Scholar]
  • Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 3223–3229. [CrossRef] [PubMed] [Google Scholar]
  • Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer’s disease: a population-based, case-control study. Ann Neurol 1993; 33: 258–266. [CrossRef] [PubMed] [Google Scholar]
  • Freir DB, Fedriani R, Scully D, Smith IM, Selkoe DJ, Walsh DM, Regan CM. Abeta oligomers inhibit synapse remodelling necessary for memory consolidation. Neurobiol Aging 2010; doi: 10.1016/j.neurobiolaging.2010.01.001 [Google Scholar]
  • Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8: 101–112. [CrossRef] [PubMed] [Google Scholar]
  • Holguin S, Martinez J, Chow C, Wurtman R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. Faseb J 2008; 22: 3938–3946. [CrossRef] [PubMed] [Google Scholar]
  • Holguin S, Huang Y, Liu J, Wurtman R. Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav Brain Res 2008; 191: 11–16. [CrossRef] [PubMed] [Google Scholar]
  • Kamphuis P, Verhey FRJMD, Olde Rikkert MGM, Twisk JWR, Swinkels SHN, Scheltens P. Efficacy of a medical food on cognition in Alzheimer’s disease: results from secondary analyses of a randomized, controlled trial. The Journal of Nutrition, Health & Aging. 2011a. [Google Scholar]
  • Kamphuis P, Verhey FRJ, Old Rikkert MGM, Twisk JWR, Swinkels SHN, Scheltens P. Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer’s disease: secondary analyses from a randomized, controlled trial. Journal of Nutrition Health and Aging. 2011b. [Google Scholar]
  • Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 1956; 222: 193–214. [PubMed] [Google Scholar]
  • Knott GW, Holtmaat A, Wilbrecht L, Welker E, Svoboda K. Spine growth precedes synapse formation in the adult neocortex in vivo. Nat Neurosci 2006; 9: 1117–1124. [CrossRef] [PubMed] [Google Scholar]
  • Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 2007; 64: 86–92. [CrossRef] [PubMed] [Google Scholar]
  • Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 2003; 60: 194–200. [CrossRef] [PubMed] [Google Scholar]
  • Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 2009; 11: 111–128. [PubMed] [Google Scholar]
  • Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5’-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 2007; 1182: 50–59. [CrossRef] [PubMed] [Google Scholar]
  • Scheff SW, Price DA. Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 2006; 9: 101–115. [Google Scholar]
  • Scheltens P, Kamphuis PJ, Verhey FR, et al. Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement 2010; 6 (1–10): e11. [Google Scholar]
  • Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer’s disease. What physicians know, and what they should know. Arch Neurol 1995; 52: 1074–1079. [Google Scholar]
  • Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27: 2866–2875. [CrossRef] [PubMed] [Google Scholar]
  • Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 2008; 14: 837–842. [CrossRef] [PubMed] [Google Scholar]
  • Shatenstein B, Kergoat MJ, Reid I. Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J Am Diet Assoc 2007; 107: 2091–2099. [CrossRef] [PubMed] [Google Scholar]
  • Teather LA, Wurtman RJ. Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J Nutr 2006; 136: 2834–2837. [PubMed] [Google Scholar]
  • Terry RD. Alzheimer’s disease and the aging brain. J Geriatr Psychiatry Neurol 2006; 19: 125–128. [CrossRef] [PubMed] [Google Scholar]
  • Terry RD, Katzman R. Life span and synapses: will there be a primary senile dementia? Neurobiol Aging 2001; 22: 347–348; discussion 353-344. [CrossRef] [PubMed] [Google Scholar]
  • Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572–580. [CrossRef] [PubMed] [Google Scholar]
  • Toni N, Teng EM, Bushong EA, et al. Ellisman MH, Gage FH. Synapse formation on neurons born in the adult hippocampus. Nat Neurosci 2007; 10: 727–734. [CrossRef] [PubMed] [Google Scholar]
  • van Wijk N, Watkins CJ, Böhlke M, et al. Dietary levels of vitamins B6, B12, and folic acid affect plasma choline concentration in rats fed a choline adequate diet. British Journal of Nutrition. 2011. [Google Scholar]
  • von Strauss E, Viitanen M, De Ronchi D, Winblad B, Fratiglioni L. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 1999; 56: 587–592. [CrossRef] [PubMed] [Google Scholar]
  • Wurtman RJ, Cansev M, Sakamoto T, Ulus IH. Use of phosphatide precursors to promote synaptogenesis. Annu Rev Nutr 2009; 29: 59–87. [CrossRef] [PubMed] [Google Scholar]
  • Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 2006; 1088: 83–92. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.